Answers are grounded in this paper and cite their sources.
Explores how timing of bariatric surgery impacts breast cancer incidence in women, suggesting timely intervention is crucial.
Purpose Obesity increases the risk of breast cancer (BC), and bariatric surgery may lower overall cancer risk. However, the impact of sleeve gastrectomy (SG) timing on cancer outcomes remains unclear. Patients and methods Using the TriNetX global health research network, we identified 4,439,072 women diagnosed with severe obesity (BMI >35 kg/m 2 ) between 2010–2019. Patients were grouped into SG and nonsurgical controls, with SG patients further stratified by surgery timing: early (≤6 months), intermediate (6–12 months), and delayed (1–3 years) post-diagnosis. Propensity score matching adjusted for demographics, comorbidities, BMI, and HbA1c. Outcomes included 5-year incidences of mortality, cancer, and metastasis. Results SG was associated with lower 5-year all-cause mortality across all timing groups compared to the control group. Early SG was significantly associated with a reduced 5-year incidence of BC (risk ratio [RR]: 0.799; 95% CI: 0.647 to 0.987; P = .037), gynecologic cancer (RR: 0.490; 95% CI: 0.378 to 0.635; P < .001), and metastasis (RR: 0.306; 95% CI: 0.230 to 0.408; P < .001). By contrast, delayed SG was associated with an increased risk of BC (RR: 1.404; 95% CI: 1.107 to 1.781; P = .005). Age-stratified analyses indicated that the association between SG timing and outcomes appeared more pronounced in patients aged ≥45 years. Conclusions Our findings highlight the importance of timely bariatric surgery in optimizing both metabolic and oncologic outcomes, particularly in older women with obesity.
No takes yet. Share an insight, caveat, or question.
Chong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: